Market Closed -
Nyse
16:00:02 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
13.01
USD
|
-2.40%
|
|
+0.23%
|
-39.63%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,060
|
28,986
|
14,699
|
3,830
|
3,568
|
2,206
|
-
|
-
|
Enterprise Value (EV)
1 |
5,986
|
29,622
|
15,051
|
4,466
|
4,026
|
2,557
|
2,282
|
2,000
|
P/E ratio
|
-60.7
x
|
-37.3
x
|
-33.6
x
|
-0.28
x
|
-16.1
x
|
-12.2
x
|
-19.8
x
|
-24.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11
x
|
26.5
x
|
7.23
x
|
1.59
x
|
1.37
x
|
0.83
x
|
0.8
x
|
0.77
x
|
EV / Revenue
|
10.8
x
|
27.1
x
|
7.4
x
|
1.86
x
|
1.55
x
|
0.96
x
|
0.83
x
|
0.7
x
|
EV / EBITDA
|
188
x
|
234
x
|
56.2
x
|
18.1
x
|
12.3
x
|
7.01
x
|
5.48
x
|
4.48
x
|
EV / FCF
|
316
x
|
-372
x
|
79.2
x
|
25.8
x
|
30.9
x
|
11.9
x
|
8.13
x
|
6.23
x
|
FCF Yield
|
0.32%
|
-0.27%
|
1.26%
|
3.87%
|
3.23%
|
8.43%
|
12.3%
|
16.1%
|
Price to Book
|
6.01
x
|
1.14
x
|
0.9
x
|
1.65
x
|
1.52
x
|
0.96
x
|
0.96
x
|
0.96
x
|
Nbr of stocks (in thousands)
|
72,382
|
144,961
|
160,087
|
161,927
|
165,557
|
169,588
|
-
|
-
|
Reference price
2 |
83.72
|
200.0
|
91.82
|
23.65
|
21.55
|
13.01
|
13.01
|
13.01
|
Announcement Date
|
20-02-26
|
21-02-24
|
22-02-22
|
23-02-22
|
24-02-20
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
553.3
|
1,094
|
2,033
|
2,407
|
2,602
|
2,665
|
2,761
|
2,864
|
EBITDA
1 |
31.83
|
126.8
|
267.8
|
246.5
|
328.1
|
364.9
|
416.1
|
446.9
|
EBIT
1 |
-80.44
|
-506.4
|
-265.6
|
-13,653
|
-248.6
|
-218.8
|
-130.4
|
-38.21
|
Operating Margin
|
-14.54%
|
-46.29%
|
-13.07%
|
-567.27%
|
-9.55%
|
-8.21%
|
-4.73%
|
-1.33%
|
Earnings before Tax (EBT)
1 |
-109.5
|
-576
|
-384.7
|
-13,663
|
-219.6
|
-180.9
|
-116.8
|
-58.13
|
Net income
1 |
-98.86
|
-485.1
|
-428.8
|
-13,660
|
-220.4
|
-173.9
|
-113.3
|
-81.22
|
Net margin
|
-17.87%
|
-44.35%
|
-21.09%
|
-567.53%
|
-8.47%
|
-6.53%
|
-4.1%
|
-2.84%
|
EPS
2 |
-1.380
|
-5.360
|
-2.730
|
-84.60
|
-1.340
|
-1.066
|
-0.6585
|
-0.5231
|
Free Cash Flow
1 |
18.97
|
-79.55
|
189.9
|
172.8
|
130.1
|
215.5
|
280.7
|
321
|
FCF margin
|
3.43%
|
-7.27%
|
9.34%
|
7.18%
|
5%
|
8.09%
|
10.17%
|
11.21%
|
FCF Conversion (EBITDA)
|
59.59%
|
-
|
70.92%
|
70.1%
|
39.64%
|
59.05%
|
67.47%
|
71.83%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-26
|
21-02-24
|
22-02-22
|
23-02-22
|
24-02-20
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
521.7
|
554.2
|
565.4
|
592.4
|
611.4
|
637.7
|
629.2
|
652.4
|
660.2
|
660.5
|
646.1
|
653.1
|
675.3
|
689.3
|
672.8
|
EBITDA
1 |
67.37
|
77.08
|
54.5
|
46.71
|
51.21
|
94.09
|
52.76
|
72.16
|
88.76
|
114.4
|
63.14
|
75.46
|
98.6
|
130.1
|
80.35
|
EBIT
1 |
-60.58
|
-41.43
|
-6,669
|
-3,097
|
-71.73
|
-3,816
|
-77.1
|
-71.64
|
-64.72
|
-35.08
|
-87.12
|
-69.53
|
-45.98
|
-14.65
|
-62.33
|
Operating Margin
|
-11.61%
|
-7.47%
|
-1,179.69%
|
-522.73%
|
-11.73%
|
-598.32%
|
-12.25%
|
-10.98%
|
-9.8%
|
-5.31%
|
-13.48%
|
-10.65%
|
-6.81%
|
-2.13%
|
-9.26%
|
Earnings before Tax (EBT)
1 |
-80.7
|
-60.73
|
-6,674
|
-3,103
|
-74.65
|
-3,812
|
-68.55
|
-66.13
|
-59.56
|
-25.38
|
-79.2
|
-61.61
|
-35.75
|
-3.971
|
-54.05
|
Net income
1 |
-84.34
|
-10.98
|
-6,675
|
-3,101
|
-73.48
|
-3,810
|
-69.23
|
-65.18
|
-57.07
|
-28.89
|
-81.89
|
-57.56
|
-34.05
|
-3.109
|
-52.46
|
Net margin
|
-16.17%
|
-1.98%
|
-1,180.6%
|
-523.56%
|
-12.02%
|
-597.46%
|
-11%
|
-9.99%
|
-8.64%
|
-4.37%
|
-12.67%
|
-8.81%
|
-5.04%
|
-0.45%
|
-7.8%
|
EPS
2 |
-0.5300
|
-0.0700
|
-41.58
|
-19.22
|
-0.4500
|
-23.49
|
-0.4200
|
-0.4000
|
-0.3500
|
-0.1700
|
-0.4900
|
-0.3432
|
-0.2133
|
-0.0275
|
-0.3023
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-10-27
|
22-02-22
|
22-04-27
|
22-07-27
|
22-10-26
|
23-02-22
|
23-04-26
|
23-07-25
|
23-10-24
|
24-02-20
|
24-04-25
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
636
|
352
|
637
|
458
|
291
|
75.3
|
-
|
Net Cash position
1 |
73.9
|
-
|
-
|
-
|
-
|
-
|
-
|
206
|
Leverage (Debt/EBITDA)
|
-
|
5.011
x
|
1.315
x
|
2.582
x
|
1.395
x
|
0.7952
x
|
0.1806
x
|
-
|
Free Cash Flow
1 |
19
|
-79.6
|
190
|
173
|
130
|
206
|
284
|
321
|
ROE (net income / shareholders' equity)
|
-9.75%
|
-5.74%
|
-2.69%
|
-149%
|
-9.51%
|
-6.46%
|
-5.5%
|
-4.98%
|
ROA (Net income/ Total Assets)
|
-6.31%
|
-5.01%
|
-2.42%
|
-2.15%
|
-5.04%
|
-3.69%
|
-2.7%
|
-1.94%
|
Assets
1 |
1,566
|
9,679
|
17,745
|
635,150
|
4,369
|
4,777
|
4,124
|
4,197
|
Book Value Per Share
2 |
13.90
|
175.0
|
102.0
|
14.30
|
14.10
|
13.60
|
13.60
|
13.60
|
Cash Flow per Share
2 |
0.4200
|
-0.5900
|
1.240
|
1.210
|
2.130
|
2.070
|
2.340
|
2.680
|
Capex
1 |
10.9
|
26
|
63.9
|
173
|
156
|
142
|
145
|
153
|
Capex / Sales
|
1.97%
|
2.38%
|
3.15%
|
7.18%
|
6.01%
|
5.32%
|
5.27%
|
5.35%
|
Announcement Date
|
20-02-26
|
21-02-24
|
22-02-22
|
23-02-22
|
24-02-20
|
-
|
-
|
-
|
Last Close Price
13.01
USD Average target price
18.1
USD Spread / Average Target +39.16% Consensus |
1st Jan change
|
Capi.
|
---|
| -39.63% | 2.2B | | +40.45% | 2.68B | | +22.83% | 527M | | +42.77% | 467M | | -64.56% | 156M | | -31.65% | 85.12M |
Telemedicine Services
|